Filament Health Corp Cash Flow Conversion Efficiency

Latest as of March 2025: -0.228x

Filament Health Corp cash flow conversion efficiency. Based on the latest financial reports, Filament Health Corp (FH) has a cash flow conversion efficiency ratio of -0.228x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-221.75K ≈ $-160.41K USD) by net assets (CA$974.38K ≈ $704.85K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Filament Health Corp (2020–2024)

Cash flow conversion efficiency of Filament Health Corp from 2020 to 2024. This chart illustrates how Filament Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Filament Health Corp stock price for real-time trading data and today's change.

Filament Health Corp Cash Flow Conversion Ratio Explained

Filament Health Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Filament Health Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Filament Health Corp ranked by their cash flow conversion efficiency. Also see market cap of Filament Health Corp for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Starbreeze AB (publ) ST:STAR-A	-0.015x
Westar Resources Ltd AU:WSR	-0.269x
Hitek Global Inc. NASDAQ:HKIT	-0.007x
Dotdigital Group Plc LSE:DOTD	0.067x
Prominence Energy Ltd AU:PRM	-0.075x
Lifeclean International AB ST:LCLEAN	-1.045x
ORIGEN RESOURCES INC. NEW F:4VXA	N/A
Somero Enterprise Inc LSE:SOM	0.172x

Annual Cash Flow Conversion Efficiency for Filament Health Corp (2020–2024)

The table below shows the annual cash flow conversion efficiency of Filament Health Corp from 2020 to 2024. Review Filament Health Corp (FH) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$1.75 Million ≈ $1.26 Million	CA$-2.29 Million ≈ $-1.66 Million	-1.310x	+22.06%
2023-12-31	CA$2.49 Million ≈ $1.80 Million	CA$-4.19 Million ≈ $-3.03 Million	-1.681x	-38.80%
2022-12-31	CA$3.19 Million ≈ $2.31 Million	CA$-3.87 Million ≈ $-2.80 Million	-1.211x	-270.68%
2021-12-31	CA$16.55 Million ≈ $11.97 Million	CA$-5.41 Million ≈ $-3.91 Million	-0.327x	-247.81%
2020-12-31	CA$813.64K ≈ $588.58K	CA$-76.42K ≈ $-55.28K	-0.094x	--

About Filament Health Corp

NEO:FH Canada

Market Cap

$1.89 Million

CA$2.62 Million CAD

Market Cap Rank

#30113 Global

#1479 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.01

All Time High

CA$0.40